acetyl-dl-leucine has been researched along with Idiopathic Parkinson Disease in 1 studies
acetylleucine: used for treating vestibular-related imbalance and vertigo
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Z | 1 |
| Lian, C | 1 |
| Pan, L | 1 |
| Lai, W | 1 |
| Zhang, F | 1 |
| Peng, L | 1 |
| Zhou, S | 1 |
| Zhao, G | 1 |
| Yang, X | 1 |
| Zhang, G | 1 |
| Tan, Z | 1 |
| Wang, Y | 1 |
1 other study available for acetyl-dl-leucine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain-Gut Axis; Disease Models, Animal; Dopam | 2023 |